8.450USD+0.96%Mkt Cap: 435.99M USDP/E: —Last update: 2026-05-22
Emergent BioSolutions Inc., a life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States, Canada, and internationall…
Industry Peers
Drug Manufacturers - Specialty & Genericloading…
Indicators:|
Key Statistics
Company
Market Cap435.99M USD
Enterprise Value856.16M USD
Revenue (TTM)676.80M USD
Gross Profit379.00M USD
Net Income (TTM)52.60M USD
Revenue/Share12.80 USD
Last Price8.450 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees900
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINUS29089Q1058
Valuation
P/E (Trailing)—
P/E (Forward)2.80
PEG0.38
EV/EBITDA5.14
EV/Revenue1.27
P/S0.64
P/B0.83
EPS (TTM)-0.19
EPS (Forward)2.99
52W Range
5.62034% of range14.06
52W High14.06 USD
52W Low5.620 USD
Profitability
Gross Margin53.74%
Oper. Margin6.79%
EBITDA Margin24.63%
Profit Margin7.46%
ROE10.07%
ROA3.99%
Growth
Revenue Growth-29.70%
Earnings Growth-93.80%
Cash Flow & Leverage
Operating CF170.60M USD
CapEx (TTM)13.80M USD
FCF Margin37.86%
FCF Yield58.77%
Net Debt424.30M USD
Net Debt/EBITDA2.55
Balance Sheet
Debt/Equity1.09
Current Ratio4.29
Quick Ratio1.90
Book Value/Sh10.10 USD
Cash/Share3.107 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)12.00 USD
Target Range12.00 USD – 12.00 USD
# Analysts2
Ownership
Shares Out.51.60M
Float50.56M
Insiders3.86%
Institutions85.69%
Short Interest
Short Ratio15.4d
Short % Float19.25%
Short % Out.18.95%
Shares Short9.78M
Short (prev mo.)9.65M
Technical
SMA 508.311 (+1.7%)
SMA 2009.732 (-13.2%)
Beta2.33
S&P 52W Chg28.31%
Avg Vol (30d)671.52K
Avg Vol (10d)660.85K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—